Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens

Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor immunobiology is incomplete. While hundreds of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Whiteaker, Jeffrey R., Lundeen, Rachel A., Zhao, Lei, Schoenherr, Regine M., Burian, Aura, Huang, Dongqing, Voytovich, Ulianna, Wang, Tao, Kennedy, Jacob J., Ivey, Richard G., Lin, Chenwei, Murillo, Oscar D., Lorentzen, Travis D., Thiagarajan, Mathangi, Colantonio, Simona, Caceres, Tessa W., Roberts, Rhonda R., Knotts, Joseph G., Reading, Joshua J., Kaczmarczyk, Jan A., Richardson, Christopher W., Garcia-Buntley, Sandra S., Bocik, William, Hewitt, Stephen M., Murray, Karen E., Do, Nhan, Brophy, Mary, Wilz, Stephen W., Yu, Hongbo, Ajjarapu, Samuel, Boja, Emily, Hiltke, Tara, Rodriguez, Henry, Paulovich, Amanda G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632241/
https://www.ncbi.nlm.nih.gov/pubmed/34858420
http://dx.doi.org/10.3389/fimmu.2021.765898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632241/
https://www.ncbi.nlm.nih.gov/pubmed/34858420
http://dx.doi.org/10.3389/fimmu.2021.765898

Ejemplares similares